[EN] CDK8 INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE CDK8 ET APPLICATIONS DE CEUX-CI
申请人:NIMBUS IRIS INC
公开号:WO2014194201A2
公开(公告)日:2014-12-04
The present invention provides methods of using compounds of formula I: and compositions thereof for the inhibition of CDK8, and the treatment of CDK8-mediated disorders.
本发明提供了使用式I的化合物及其组合物来抑制CDK8和治疗CDK8介导的疾病的方法。
IRAK INHIBITORS AND USES THEREOF
申请人:Nimbus Iris, Inc.
公开号:US20140194417A1
公开(公告)日:2014-07-10
The present invention provides compounds, compositions thereof, and methods of using the same.
本发明提供了化合物、其组合物以及使用这些化合物的方法。
US9175007B2
申请人:——
公开号:US9175007B2
公开(公告)日:2015-11-03
US9751892B2
申请人:——
公开号:US9751892B2
公开(公告)日:2017-09-05
[EN] IRAK INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS D'IRAK ET LEURS UTILISATIONS
申请人:NIMBUS IRIS INC
公开号:WO2014110114A1
公开(公告)日:2014-07-17
The present invention provides compounds, compositions thereof, and methods of using the same. The search for new therapeutic agents has been greatly aided in recent years by a better understanding of the structure of enzymes and other biomolecules associated with diseases. One important class of enzymes that has been the subject of extensive study is the protein kinase family.